Healthy volunteers and people with Type 2 Diabetes are needed to participate in an aspirin research study at the Duke Clinical Research Unit. The study will evaluate the effect of aspirin and ticagrelor (an antiplatelet agent similar to aspirin) on the genomic profiles of whole blood and platelets.
Study participation will involve 5 or 6 visits to the DCRU over the course of approximately 5 months. The aspirin & ticagrelor therapy for participants will last 16 weeks. Financial compensation is provided for participation.
Healthy volunteers must be between the ages of 30 and 75 years old, use no medications, and be non-smokers. Participants with Type 2 Diabetes must be at least 45 years old if male and at least 50 years old if female.
For more information, please contact the DCRU at 919-613-6244 or firstname.lastname@example.org
For more information, contact Duke Clinical Research Unit at 919-613-6244.